In this study, we demonstrated for the first time that CRTC2 is overexpressed in ovarian cancer and promotes ovarian cancer proliferation and invasion, and demonstrated that its overexpression is significantly associated with poor patient survival. Here, CRTC2 is linked to ovarian carcinoma.